Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106652212 | 10665221 | 2 | F | 20120606 | 20160715 | 20141219 | 20160721 | EXP | JP-SA-2014SA173628 | AVENTIS | 30.00 | YR | A | F | Y | 54.00000 | KG | 20160721 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106652212 | 10665221 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | UNKNOWN | 103869 | 65 | MG | POWDER FOR SOLUTION FOR INFUSION | QD | ||||||
| 106652212 | 10665221 | 2 | C | FUNGUARD | MICAFUNGIN SODIUM | 1 | 0 | ||||||||||||
| 106652212 | 10665221 | 3 | C | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | 0 | ||||||||||||
| 106652212 | 10665221 | 4 | C | DEPAKENE | VALPROIC ACID | 1 | 0 | ||||||||||||
| 106652212 | 10665221 | 5 | C | BUSULFAN. | BUSULFAN | 1 | 0 | ||||||||||||
| 106652212 | 10665221 | 6 | C | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | 0 | ||||||||||||
| 106652212 | 10665221 | 7 | C | MELPHALAN | MELPHALAN | 1 | 0 | ||||||||||||
| 106652212 | 10665221 | 8 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | 0 | ||||||||||||
| 106652212 | 10665221 | 9 | C | RECOMODULIN | THROMBOMODULIN ALFA | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106652212 | 10665221 | 1 | Bone marrow conditioning regimen |
| 106652212 | 10665221 | 2 | Infection prophylaxis |
| 106652212 | 10665221 | 3 | Bone marrow conditioning regimen |
| 106652212 | 10665221 | 4 | Convulsion prophylaxis |
| 106652212 | 10665221 | 5 | Bone marrow conditioning regimen |
| 106652212 | 10665221 | 6 | Infection prophylaxis |
| 106652212 | 10665221 | 7 | Bone marrow conditioning regimen |
| 106652212 | 10665221 | 8 | Prophylaxis against graft versus host disease |
| 106652212 | 10665221 | 9 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106652212 | 10665221 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106652212 | 10665221 | Thrombotic microangiopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106652212 | 10665221 | 1 | 20120525 | 20120527 | 0 | |
| 106652212 | 10665221 | 2 | 20120514 | 20120709 | 0 | |
| 106652212 | 10665221 | 3 | 20120524 | 20120529 | 0 | |
| 106652212 | 10665221 | 4 | 20120524 | 20120613 | 0 | |
| 106652212 | 10665221 | 5 | 20120526 | 20120527 | 0 | |
| 106652212 | 10665221 | 6 | 20120527 | 20120607 | 0 | |
| 106652212 | 10665221 | 7 | 20120528 | 20120529 | 0 | |
| 106652212 | 10665221 | 8 | 20120530 | 20120606 | 0 | |
| 106652212 | 10665221 | 9 | 20120605 | 20120709 | 0 |